TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25664999

Group type: EXPERIMENTAL
Intervention: Multi-nutrient supplement (550 mg DHA, 550 mg EPA, 10 µg vitamin D3 and 8 g whey protein)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 25416084

Group type: EXPERIMENTAL
Intervention: Willingness to participate in RCTs
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Negative impact of weight on life
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Feeling unsatisfied/very unsatisfied with weight loss ability
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Perception of weight control vs diabetes control
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Negative impact on life due to weight vs diabetes
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Feeling unsatisfied with weight loss ability
Number of subjects: 1820
Study: 22205196

Group type: EXPERIMENTAL
Intervention: NLMEM-based analysis of somatropin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NLMEM-based analysis of epoetin-α
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noncompartmental analysis (NCA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NLMEM
Number of subjects: 0
Study: 19204860

Group type: EXPERIMENTAL
Intervention: High organizational assistance
Number of subjects: 296

Group type: COMPARATOR
Intervention: Low organizational assistance
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: High severity of smoke-free policy
Number of subjects: 296

Group type: COMPARATOR
Intervention: Low severity of smoke-free policy
Number of subjects: 296
Study: 17710152

Group type: EXPERIMENTAL
Intervention: HBV vaccination in infancy
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Booster dose of HBV vaccine
Number of subjects: 492

Group type: COMPARATOR
Intervention: Unvaccinated control group
Number of subjects: 492
Study: 15567983

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei supplementation (750 mg daily containing 16 billion bacteria)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard quadruple therapy without Lactobacillus casei supplementation
Number of subjects: 70
Study: 12020142

Group type: EXPERIMENTAL
Intervention: Alendronate, 10 mg/d
Number of subjects: 327

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327
Study: 9609268

Group type: EXPERIMENTAL
Intervention: 200 microg misoprostol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 400 microg misoprostol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 7709043

Group type: EXPERIMENTAL
Intervention: Formal pulmonary rehabilitation program
Number of subjects: 30

Group type: COMPARATOR
Intervention: No formal pulmonary rehabilitation
Number of subjects: 30
Study: 2693683

Group type: EXPERIMENTAL
Intervention: 1% metronidazole gel
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 10
Study: 856386

Group type: EXPERIMENTAL
Intervention: Temperature chart interpretation by gynaecologists (experts)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Temperature chart interpretation by non-experts (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Temperature chart interpretation (both groups)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Temperature charts from normal subjects
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Temperature charts from infertile patients
Number of subjects: 60
Study: 30452705

Group type: EXPERIMENTAL
Intervention: Active condition (n = 63)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control condition (n = 64)
Number of subjects: 127
Study: 31778431

Group type: EXPERIMENTAL
Intervention: Viscosupplementation (VS, n=16)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Viscosupplementation plus dexamethasone (VD, n=16)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DX, n=12)
Number of subjects: 44
Study: 28351393

Group type: EXPERIMENTAL
Intervention: Honey supplementation (20 g/day for 12 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (smokers without honey)
Number of subjects: 64
Study: 26016871

Group type: EXPERIMENTAL
Intervention: Rapid Diagnostic Tests (RDTs)
Number of subjects: 646

Group type: COMPARATOR
Intervention: Microscopy
Number of subjects: 646

Group type: COMPARATOR
Intervention: Clinical Diagnosis
Number of subjects: 646
Study: 24365449

Group type: EXPERIMENTAL
Intervention: Rifaximin (550 mg, twice daily)
Number of subjects: 392
Study: 22034767

Group type: EXPERIMENTAL
Intervention: Spinal manipulative treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other advocated therapies
Number of subjects: 0
Study: 20441066

Group type: EXPERIMENTAL
Intervention: Intervention (Incredible Years Teacher Training Programme + social and emotional skills lessons)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 135
Study: 16869815

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) 10 mg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) 20 mg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) 40 mg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) multiple doses
Number of subjects: 42

Group type: COMPARATOR
Intervention: Food effect on Adefovir dipivoxil (ADV)
Number of subjects: 42
Study: 15258862

Group type: EXPERIMENTAL
Intervention: Rapid-absorbing gut suture (RG)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Octylcyanoacrylate (OC)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Nylon suture (NL)
Number of subjects: 145
Study: 11720199

Group type: EXPERIMENTAL
Intervention: 30 microg ethinyl estradiol
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 20 microg ethinyl estradiol
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both OCs
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Reduction from 30 microg to 20 microg ethinyl estradiol
Number of subjects: 46
Study: 9452157

Group type: EXPERIMENTAL
Intervention: Nitrate therapy (intravenous infusion or orally)
Number of subjects: 966
Study: 8259188

Group type: EXPERIMENTAL
Intervention: 9 million units of recombinant interferon alfa-2a (three times a week for 48 weeks)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 3 million units of recombinant interferon alfa-2a (three times a week for 48 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 9 million units of recombinant interferon alfa-2a
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 3 million units of recombinant interferon alfa-2a
Number of subjects: 42
Study: 3111690

Group type: EXPERIMENTAL
Intervention: Isosorbide 5‐mononitrate (IS 5‐MN) given orally
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isosorbide dinitrate (ISDN)
Number of subjects: 10
Study: 30292451

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 68
Study: 27737686

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention emphasizing COPD management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care and a COPD education pamphlet (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention
Number of subjects: 0
Study: 25136050

Group type: EXPERIMENTAL
Intervention: HPV4 vaccine
Number of subjects: 1781

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 1781
Study: 22894624

Group type: EXPERIMENTAL
Intervention: AMR101 4 g/day
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: AMR101 2 g/day
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229
Study: 19821184

Group type: EXPERIMENTAL
Intervention: Psychotherapy (for subgroup of n=101)
Number of subjects: 416

Group type: COMPARATOR
Intervention: All patients seeking treatment (n=416)
Number of subjects: 416
Study: 17209220

Group type: EXPERIMENTAL
Intervention: Vitamin supplements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multivitamins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin and multivitamin-mineral supplements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study: 15902439

Group type: EXPERIMENTAL
Intervention: p-[(123)I]iodo-L-phenylalanine (IPA) SPECT
Number of subjects: 45
Study: 12054161

Group type: EXPERIMENTAL
Intervention: 150 mg/day of pamidronate
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 10080463

Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 395

Group type: COMPARATOR
Intervention: t-PA
Number of subjects: 395
Study: 7744191

Group type: EXPERIMENTAL
Intervention: Bambuterol 10 mg
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Bambuterol 20 mg
Number of subjects: 487

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 487
Study: 1539551

Group type: EXPERIMENTAL
Intervention: Natural head position (NHP)
Number of subjects: 52
Study: 3516296

Group type: EXPERIMENTAL
Intervention: Terodiline 25 mg bid
Number of subjects: 18
Study: 29685325

Group type: EXPERIMENTAL
Intervention: Schizophrenia patients under stress conditions (no stress, noise, social stress)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Schizophrenia patients
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Schizophrenia patients under stress conditions
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Stress management programs
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Interventions to reduce overconfidence in social cognition judgments
Number of subjects: 120
Study: 27472521

Group type: EXPERIMENTAL
Intervention: Biobehavioral intervention
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Self-care intervention
Number of subjects: 435

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: All interventions (biobehavioral, self-care, no intervention)
Number of subjects: 435
Study: 25472936

Group type: EXPERIMENTAL
Intervention: Heparin-bonded covered stents (VIABAHN® Endoprosthesis)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 141
Study: 22829211

Group type: EXPERIMENTAL
Intervention: Anger-motivated rape scenario
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Rape
Number of subjects: 134
Study: 22042106

Group type: EXPERIMENTAL
Intervention: Glutamine
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 33
Study: 18450596

Group type: EXPERIMENTAL
Intervention: Omega-3 LCPUFA (350 mg DHA and 650 mg EPA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 18473976

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (AI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0
Study: 14594184

Group type: EXPERIMENTAL
Intervention: Guided to self-hypnotic relaxation
Number of subjects: 146

Group type: COMPARATOR
Intervention: Structured empathic attention
Number of subjects: 146
Study: 10949784

Group type: EXPERIMENTAL
Intervention: Meta-analysis of randomized, controlled trials of cancer therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meta-analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meta-analysis of individual patient data
Number of subjects: 0
Study: 7762523

Group type: EXPERIMENTAL
Intervention: High-fat diet (46% of total energy)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Low-fat diet (24% of total energy)
Number of subjects: 105
Study: 2212299

Group type: COMPARATOR
Intervention: Loudness growth in 1/2-octave bands (LGOB) method using noise bands centered at 0.25, 0.5, 1.0, 2.0, and 4.0 kHz; subjective levels between threshold of hearing and 'too loud' level.
Number of subjects: 0
Study: 6102739

Group type: EXPERIMENTAL
Intervention: 6-mercaptopurine (6-MP)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 31729964

Group type: COMPARATOR
Intervention: 5-fluorouracil in the observational group for patients with pathologic complete response or yp stage I
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxaliplatin combined with 5-fluorouracil
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-fluorouracil alone
Number of subjects: 0
Study: 28880899

Group type: EXPERIMENTAL
Intervention: Moderate sedation (Ce at 50% of Ce-LOR)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Deep sedation (Ce at 75% of Ce-LOR)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Awake control state
Number of subjects: 16
Study: 25970149

Group type: EXPERIMENTAL
Intervention: One egg per day
Number of subjects: 29

Group type: COMPARATOR
Intervention: Oatmeal-based breakfast
Number of subjects: 29
Study: 23439424

Group type: EXPERIMENTAL
Intervention: Heart Rate Reserve (HRR)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Metabolic Equation for Treadmill Walking (METW)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Direct Heart Rate (DIRECT HR)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rate of Perceived Exertion (RPE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: HRR, METW, DIRECT HR
Number of subjects: 30
Study: 21733143

Group type: EXPERIMENTAL
Intervention: Dietary advice
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Nutritional supplement
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Dietary advice plus supplement
Number of subjects: 358

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Surviving beyond 26 weeks
Number of subjects: 358
Study: 19101496

Group type: EXPERIMENTAL
Intervention: Eugenol-containing temporary cement
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Eugenol-free temporary cement
Number of subjects: 25

Group type: COMPARATOR
Intervention: Untreated teeth (negative control)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Eugenol-free cement (48-h samples)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: PECAM-1 reactivity
Number of subjects: 25
Study: 17001223

Group type: EXPERIMENTAL
Intervention: Supervised physical training programme (30 min, 3 times a week for 3 months at 60-70% of VO2 peak)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Supervised physical training programme
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no change in previous physical activity)
Number of subjects: 60
Study: 12757558

Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg/d for 4 weeks and 10 mg/d per clinician's judgment thereafter)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study: 10683058

Group type: COMPARATOR
Intervention: BVM (Bag-Valve-Mask)
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: BVM followed by ETI (Endotracheal Intubation)
Number of subjects: 830
Study: 9308762

Group type: EXPERIMENTAL
Intervention: Dietary antioxidant vitamins for four weeks
Number of subjects: 15
Study: 7955807

Group type: EXPERIMENTAL
Intervention: 3 mg dihydroergotamine and 300 mg troxerutin three times a day
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 3675697

Group type: EXPERIMENTAL
Intervention: 800 micrograms MDL 646 (alprostadil analogue)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1200 micrograms MDL 646 (alprostadil analogue)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 28952413

Group type: EXPERIMENTAL
Intervention: Immediate testing phase after learning (n=30)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Delay testing phase with a 15-minute delay (n=28)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 28326681

Group type: EXPERIMENTAL
Intervention: Selumetinib (AZD6244, ARRY‐142886)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N-desmethyl-selumetinib
Number of subjects: 0
Study: 25649150

Group type: EXPERIMENTAL
Intervention: Motivational intervention (Mot; risk perception and outcome expectancies) followed by self-regulatory intervention (SelfR; perceived self-efficacy and planning)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Self-regulatory intervention (SelfR; perceived self-efficacy and planning)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Motivational intervention (Mot; risk perception and outcome expectancies)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Self-regulatory module (SelfR)
Number of subjects: 205
Study: 23948729

Group type: EXPERIMENTAL
Intervention: Donepezil at night (n=54)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Galantamine in the morning (n=38)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Donepezil in the morning (n=24)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Donepezil at night (n=30)
Number of subjects: 92
Study: 20684322

Group type: EXPERIMENTAL
Intervention: L-carnitine (2 g/d) and vitamin E
Number of subjects: 135

Group type: COMPARATOR
Intervention: Vitamin E only
Number of subjects: 135
Study: 18839655

Group type: EXPERIMENTAL
Intervention: Topical application of human placenta purified extract (PE)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Topical application of povidone iodine (PI)
Number of subjects: 79
Study: 16649186

Group type: EXPERIMENTAL
Intervention: Rituximab 500 mg
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Rituximab 1000 mg
Number of subjects: 465

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 465
Study: 14657817

Group type: EXPERIMENTAL
Intervention: 1.25 mg levalbuterol
Number of subjects: 482

Group type: COMPARATOR
Intervention: 2.5 mg racemic albuterol
Number of subjects: 482
Study: 10731402

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 481

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 481
Study: 8783700

Group type: EXPERIMENTAL
Intervention: Oral nonabsorbable antibiotics for selective bowel decontamination (SBD)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Conventional prophylaxis with systemic antibiotics (Control)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Overall rates of bacterial and/or yeast infections
Number of subjects: 69
Study: 1628168

Group type: EXPERIMENTAL
Intervention: Scoring system for skin involvement
Number of subjects: 12

Group type: COMPARATOR
Intervention: Shaded manikin method for estimating skin involvement
Number of subjects: 12
Study: 6421196

Group type: EXPERIMENTAL
Intervention: High nitrogen intake (15 mg nitrogen per kcal REE, approximately 21 g/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Low nitrogen intake (7.5 mg nitrogen per kcal REE, approximately 11 g/day)
Number of subjects: 8
Study: 31062950

Group type: COMPARATOR
Intervention: HIIT (Group 1), four runs at maximal speed with 30 s active recovery (total: 48 runs)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: proHIIT (Group 2), 4 runs at maximal speed with 30 s active recovery with one extra repetition every week (up to seven runs, for a total of 66 runs)
Number of subjects: 34
Study: 30169298

Group type: EXPERIMENTAL
Intervention: Family Integrated Care (FICare)
Number of subjects: 1786

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 1786
Study: 27861670

Group type: EXPERIMENTAL
Intervention: Immediate implant placement (test group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Delayed implant placement (control group)
Number of subjects: 40
Study: 25386678

Group type: EXPERIMENTAL
Intervention: Post discharge phone call
Number of subjects: 328
Study: 22176154

Group type: EXPERIMENTAL
Intervention: FreeStyle Lite®
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: FreeStyle Freedom Lite
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Accu‐Chek® Aviva
Number of subjects: 501

Group type: COMPARATOR
Intervention: Contour®
Number of subjects: 501

Group type: COMPARATOR
Intervention: OneTouch® UltraEasy®
Number of subjects: 501
Study: 19344527

Group type: EXPERIMENTAL
Intervention: High-dose rate (HDR) brachytherapy
Number of subjects: 2065
Study: 17785979

Group type: EXPERIMENTAL
Intervention: 1.5 g chilli powder twice daily along with identical fiber and analgesics
Number of subjects: 56

Group type: COMPARATOR
Intervention: Analgesics and fiber supplement alone
Number of subjects: 56
Study: 14628149

Group type: EXPERIMENTAL
Intervention: IR laser treatment
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham laser (control)
Number of subjects: 46
Study: 12147561

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control
Number of subjects: 42
Study: 9818307

Group type: EXPERIMENTAL
Intervention: Goal-focused group psychotherapy (GFGP)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Reminiscence therapy (RT)
Number of subjects: 13
Study: 8130021

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate (8 mmol loading dose over 5 minutes plus 65 mmol over 24 hours)
Number of subjects: 2316

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 2316
Study: 2673331

Group type: EXPERIMENTAL
Intervention: Methotrexate and cyclosporin (n = 22)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Methotrexate alone (n = 24)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 46
Study: 31212115

Group type: EXPERIMENTAL
Intervention: Insulin-requiring diabetics (IRD)
Number of subjects: 798592

Group type: EXPERIMENTAL
Intervention: Non-insulin requiring diabetics (NIRD)
Number of subjects: 798592

Group type: COMPARATOR
Intervention: Anticoagulation
Number of subjects: 798592
Study: 28971636

Group type: EXPERIMENTAL
Intervention: Lornoxicam (20 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Paracetamol (1000 mg)
Number of subjects: 80
Study: 25750093

Group type: EXPERIMENTAL
Intervention: Mud-bath therapy (MBT)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (regular care routine)
Number of subjects: 95
Study: 23743715

Group type: EXPERIMENTAL
Intervention: Circumventing obstacles instead of rotating shoulders when the aperture was too small for straight passage.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Changes in travel path when approaching obstacles.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Medial-lateral center of mass variability during the approach to the obstacles.
Number of subjects: 12